This whitepaper explores:
With a rise in precision medicines, high value shipments and emergingshipping routes, global biopharma industry spending on temperaturecontrolled products is expected to reach $15.7 billion in 2019.1 To ensure that companies are able to navigate this new product landscape and complex routes in a cost efficient and effective way, they must rely on specialized and trusted partners.
In this report, Pharma IQ explores how these trends will affect temperature control and logistics spending in the next 12 to 24 months. All the findings from our recent survey are presented and analysed below.
Across the pharmaceutical supply chain, losses associated with temperature lapses are estimated to be worth £320bn globally. To ensure the profitability of the pharmaceutical industry and patient safety, supply chains must limit the risk of damage to products.
Warehouses are a critical area of risk due to the hectic pace of operations and potential for errors in judgment or processes by workers. To ensure the safe storage and continuity of supply for pharmaceutical products, supply chain leaders must operate with smart warehouse management in mind.
In this report, we cover five areas where a company can improve warehouse operations: